We confirmed the effects of CDK7 inhibition in another prostate cancer cell line using the same CDK7 inhibitor (YKL-5–124 [2]), and also in this case, the mRNA biosynthesis of less than four hundred genes was significantly affected (Suppl. Here, CDK7 is linked to prostate carcinoma.